Ralf Dieter Hofheinz

Ontology type: schema:Person     

Person Info


Ralf Dieter



Publications in SciGraph latest 50 shown

  • 2019-01-25 Treatment of Patients with Advanced Gastroesophageal Adenocarcinoma: Does Age Matter? in DRUGS & AGING
  • 2018-12-11 A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer in BRITISH JOURNAL OF CANCER
  • 2018-12 Impact of adjuvant chemotherapy on patients with ypT0–2 ypN0 rectal cancer after neoadjuvant chemoradiation: a cohort study from a tertiary referral hospital in WORLD JOURNAL OF SURGICAL ONCOLOGY
  • 2018-12 Influence of complete administration of adjuvant chemotherapy cycles on overall and disease-free survival in locally advanced rectal cancer: post hoc analysis of a randomized, multicenter, non-inferiority, phase 3 trial in BMC CANCER
  • 2018-10 Adenokarzinom des Magens: STO-0417 Studie (MOONLIGHT) – Phase II-Studie in FORUM
  • 2018-03 PSA response to cabazitaxel is associated with improved progression-free survival in metastatic castration-resistant prostate cancer: the non-interventional QoLiTime study in WORLD JOURNAL OF UROLOGY
  • 2017-12 The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction – a phase III trial of the German AIO/CAO-V/CAOGI in BMC CANCER
  • 2017-05 HER2 testing in gastric cancer: results of a German expert meeting in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2016-12 Patient preferences for palliative treatment of locally advanced or metastatic gastric cancer and adenocarcinoma of the gastroesophageal junction: a choice-based conjoint analysis study from Germany in BMC CANCER
  • 2016-11 Impact of tumour RAS/BRAF status in a first-line study of panitumumab + FOLFIRI in patients with metastatic colorectal cancer in BRITISH JOURNAL OF CANCER
  • 2016-10 Carcinoma of the colon and rectum with deregulation of insulin-like growth factor 2 signaling: clinical and molecular implications in JOURNAL OF GASTROENTEROLOGY
  • 2016-07 HER2-Testung beim Magenkarzinom in DER PATHOLOGE
  • 2016-05 Peritonealkarzinose bei gastrointestinalen Malignomen in DER ONKOLOGE
  • 2016-01 Reply to the Letter to the Editor in GASTRIC CANCER
  • 2015-12 CoCStom trial: study protocol for a randomised trial comparing completeness of adjuvant chemotherapy after early versus late diverting stoma closure in low anterior resection for rectal cancer in BMC CANCER
  • 2015-12 Acute small-bowel toxicity during neoadjuvant combined radiochemotherapy in locally advanced rectal cancer: determination of optimal dose-volume cut-off value predicting grade 2–3 diarrhoea in RADIATION ONCOLOGY
  • 2015-04 Dose-dependent changes in renal 1H-/23Na MRI after adjuvant radiochemotherapy for gastric cancer in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2015-04 Erratum zu: Perioperative (Radio-)Chemotherapie des lokal fortgeschrittenen Rektumkarzinoms in DER ONKOLOGE
  • 2015-02 Behandlungsalgorithmus zum Rektumkarzinom in DER ONKOLOGE
  • 2015-02 Rektumkarzinom – Interdisziplinarität im Mittelpunkt in DER ONKOLOGE
  • 2015-02 Perioperative (Radio-)Chemotherapie des lokal fortgeschrittenen Rektumkarzinoms in DER ONKOLOGE
  • 2014-12 Bevacizumab in first-line treatment of elderly patients with metastatic colorectal cancer: German community-based observational cohort study results in BMC CANCER
  • 2014-12 VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO) in BMC CANCER
  • 2014-05 Mitomycin C and capecitabine in pretreated patients with metastatic gastric cancer: a multicenter phase II study in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2014-02 Patients with malignant hematological disorders treated on a palliative care unit: prognostic impact of clinical factors in ANNALS OF HEMATOLOGY
  • 2014-01 Quality of life of older adult patients receiving docetaxel-based chemotherapy triplets for esophagogastric adenocarcinoma: a randomized study of the Arbeitsgemeinschaft Internistische Onkologie (AIO) in GASTRIC CANCER
  • 2013-10 Analkarzinom in COLOPROCTOLOGY
  • 2013-09 Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205 in BRITISH JOURNAL OF CANCER
  • 2013-06 Perioperative Therapie des lokal fortgeschrittenen Rektumkarzinoms in COLOPROCTOLOGY
  • 2013-05 Adjuvant IMRT/XELOX radiochemotherapy improves long-term overall- and disease-free survival in advanced gastric cancer in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2013-02 Metastatic esophagogastric adenocarcinoma: trends in first-line treatment and predictive factors for the implementation of HER2 testing in clinical practice during the first year after trastuzumab market approval in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2013-01 WNT6 is a novel target gene of caveolin-1 promoting chemoresistance to epirubicin in human gastric cancer cells in ONCOGENE
  • 2012-12 Hypofractionated image-guided breath-hold SABR (Stereotactic Ablative Body Radiotherapy) of liver metastases – clinical results in RADIATION ONCOLOGY
  • 2012-12 Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study in BMC CANCER
  • 2012-12 Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma in BMC CANCER
  • 2012-12 Functional protease profiling with reporter peptides in serum specimens of colorectal cancer patients: demonstration of its routine diagnostic applicability in JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
  • 2012-11 Capecitabine-associated hand–foot–skin reaction is an independent clinical predictor of improved survival in patients with colorectal cancer in BRITISH JOURNAL OF CANCER
  • 2012-10 Perioperative Therapie des lokal fortgeschrittenen Rektumkarzinoms in DER ONKOLOGE
  • 2012-08 Analkarzinom in DER ONKOLOGE
  • 2012-03 Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer in BRITISH JOURNAL OF CANCER
  • 2012-01 First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2011-12 Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy in BMC CANCER
  • 2010-12 Efficacy and safety of capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated pancreatic, gallbladder, and bile duct carcinoma in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2010-12 Induction Chemotherapy before Chemoradiotherapy and Surgery for Locally Advanced Rectal Cancer in STRAHLENTHERAPIE UND ONKOLOGIE
  • 2009-12 A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancer in BMC SURGERY
  • 2008-03 Tumor response to neoadjuvant chemoradiation in rectal cancer: predictor for surgical morbidity? in INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
  • 2008-01 Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial in BRITISH JOURNAL OF CANCER
  • 2007-12 Capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated tumours: results of an extended phase-I trial in BRITISH JOURNAL OF CANCER
  • 2007-11 Analkarzinom: Therapieoptionen beim lokalisierten und disseminierten Rezidiv in DER ONKOLOGE
  • 2007-03 A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer in BRITISH JOURNAL OF CANCER
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.411778.c", 
              "type": "Organization"
            "isCurrent": true, 
            "type": "OrganizationRole"
            "id": "https://www.grid.ac/institutes/grid.4562.5", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.5601.2", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.5802.f", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.412282.f", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.10392.39", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.7700.0", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.468184.7", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.275559.9", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.38142.3c", 
            "type": "Organization"
        "familyName": "Hofheinz", 
        "givenName": "Ralf Dieter", 
        "id": "sg:person.01370537467.21", 
        "sameAs": [
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:52", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_593.json", 
        "type": "Person"

    Download the RDF metadata as:  json-ld nt turtle xml License info


    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01370537467.21'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01370537467.21'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01370537467.21'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01370537467.21'


    This table displays all metadata directly associated to this object as RDF triples.

    34 TRIPLES      10 PREDICATES      20 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01370537467.21 schema:affiliation N825499092f2d44fab221c228832e3227
    2 https://www.grid.ac/institutes/grid.10392.39
    3 https://www.grid.ac/institutes/grid.275559.9
    4 https://www.grid.ac/institutes/grid.38142.3c
    5 https://www.grid.ac/institutes/grid.412282.f
    6 https://www.grid.ac/institutes/grid.4562.5
    7 https://www.grid.ac/institutes/grid.468184.7
    8 https://www.grid.ac/institutes/grid.5601.2
    9 https://www.grid.ac/institutes/grid.5802.f
    10 https://www.grid.ac/institutes/grid.7700.0
    11 schema:familyName Hofheinz
    12 schema:givenName Ralf Dieter
    13 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01370537467.21
    14 schema:sdDatePublished 2019-03-07T14:52
    15 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    16 schema:sdPublisher N3fa6c7ddca25425e8dd1ab573811e104
    17 sgo:license sg:explorer/license/
    18 sgo:sdDataset persons
    19 rdf:type schema:Person
    20 N3fa6c7ddca25425e8dd1ab573811e104 schema:name Springer Nature - SN SciGraph project
    21 rdf:type schema:Organization
    22 N825499092f2d44fab221c228832e3227 schema:affiliation https://www.grid.ac/institutes/grid.411778.c
    23 sgo:isCurrent true
    24 rdf:type schema:OrganizationRole
    25 https://www.grid.ac/institutes/grid.10392.39 schema:Organization
    26 https://www.grid.ac/institutes/grid.275559.9 schema:Organization
    27 https://www.grid.ac/institutes/grid.38142.3c schema:Organization
    28 https://www.grid.ac/institutes/grid.411778.c schema:Organization
    29 https://www.grid.ac/institutes/grid.412282.f schema:Organization
    30 https://www.grid.ac/institutes/grid.4562.5 schema:Organization
    31 https://www.grid.ac/institutes/grid.468184.7 schema:Organization
    32 https://www.grid.ac/institutes/grid.5601.2 schema:Organization
    33 https://www.grid.ac/institutes/grid.5802.f schema:Organization
    34 https://www.grid.ac/institutes/grid.7700.0 schema:Organization

    Preview window. Press ESC to close (or click here)